Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems
- PMID: 23265686
- DOI: 10.1016/j.pain.2012.11.007
Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems
Abstract
Pain is a negative emotional experience that is modulated by a variety of psychological factors through different inhibitory systems. For example, endogenous opioids and cannabinoids have been found to be involved in stress and placebo analgesia. Here we show that when the meaning of the pain experience is changed from negative to positive through verbal suggestions, the opioid and cannabinoid systems are co-activated and these, in turn, increase pain tolerance. We induced ischemic arm pain in healthy volunteers, who had to tolerate the pain as long as possible. One group was informed about the aversive nature of the task, as done in any pain study. Conversely, a second group was told that the ischemia would be beneficial to the muscles, thus emphasizing the usefulness of the pain endurance task. We found that in the second group pain tolerance was significantly higher compared to the first one, and that this effect was partially blocked by the opioid antagonist naltrexone alone and by the cannabinoid antagonist rimonabant alone. However, the combined administration of naltrexone and rimonabant antagonized the increased tolerance completely. Our results indicate that a positive approach to pain reduces the global pain experience through the co-activation of the opioid and cannabinoid systems. These findings may have a profound impact on clinical practice. For example, postoperative pain, which means healing, can be perceived as less unpleasant than cancer pain, which means death. Therefore, the behavioral and/or pharmacological manipulation of the meaning of pain can represent an effective approach to pain management.
Copyright © 2012 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
Comment in
-
The inner experience and neurobiology of placebo analgesia. Can these perspectives be integrated?Pain. 2013 Mar;154(3):328-329. doi: 10.1016/j.pain.2012.12.011. Epub 2012 Dec 28. Pain. 2013. PMID: 23333053 No abstract available.
References
-
- Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. J Neurosci. 1999;19:484-494.
-
- Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci. 1984;7:309-338.
-
- Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med. 2011;17:1228-1230.
-
- Borsook D, Becerra L, Carlezon WA Jr, Shaw M, Renshaw P, Elman I, Levine J. Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain. 2009;11:7-20.
-
- Cormie PJ, Nairn M. Guideline development group. Control of pain in adults with cancer: summary of SIGN guidelines. BMJ. 2008;337:a2154.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
